Chemo- and Regioselective Lysine Modification on Native Proteins.

about

Chemo- and Regioselective Lysine Modification on Native Proteins.

Item

http://www.wikidata.org/entity/Q53081947

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Chemo- and Regioselective Lysine Modification on Native Proteins.

@en

Chemo- and Regioselective Lysine Modification on Native Proteins.

@nl

type

Item

label

Chemo- and Regioselective Lysine Modification on Native Proteins.

@en

Chemo- and Regioselective Lysine Modification on Native Proteins.

@nl

prefLabel

Chemo- and Regioselective Lysine Modification on Native Proteins.

@en

Chemo- and Regioselective Lysine Modification on Native Proteins.

@nl

P1476

Chemo- and Regioselective Lysine Modification on Native Proteins

@en

P2093

Ana Guerreiro

http://www.w3.org/2001/XMLSchema#string

Elizabeth Perkins

http://www.w3.org/2001/XMLSchema#string

Jean Bertoldo

http://www.w3.org/2001/XMLSchema#string

Julie Howard

http://www.w3.org/2001/XMLSchema#string

Maria J Matos

http://www.w3.org/2001/XMLSchema#string

María Maneiro

http://www.w3.org/2001/XMLSchema#string

Michael J Deery

http://www.w3.org/2001/XMLSchema#string

Nuria Martínez-Sáez

http://www.w3.org/2001/XMLSchema#string

Pedro M S D Cal

http://www.w3.org/2001/XMLSchema#string

P2860

Synthesis of site-specific antibody-drug conjugates using unnatural amino acids

Electrophilic affibodies forming covalent bonds to protein targets

Unraveling the Interaction between FcRn and Albumin: Opportunities for Design of Albumin-Based Therapeutics

Observation of covalent intermediates in an enzyme mechanism at atomic resolution

Characterization, kinetics, and crystal structures of fructose-1,6-bisphosphate aldolase from the human parasite, Giardia lamblia

Chemoselective small molecules that covalently modify one lysine in a non-enzyme protein in plasma

Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK)

Chemical genetic strategy for targeting protein kinases based on covalent complementarity

Evolution of a designed retro-aldolase leads to complete active site remodeling

Choosing an effective protein bioconjugation strategy

P304

4004-4017

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/JACS.7B12874

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

140

http://www.w3.org/2001/XMLSchema#string

P50

Gonçalo J. L. Bernardes

P577

2018-03-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29473744

http://www.w3.org/2001/XMLSchema#string

P932

5880509

http://www.w3.org/2001/XMLSchema#string